MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, EVMN made $10M in revenue. -$12.475M in net income. Net profit margin of -124.75%.

Income Overview

Revenue
$10M
Net Income
-$12.475M
Net Profit Margin
-124.75%
EPS
-$8.07
Unit: Million (M) dollars

Unit: Million (M) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
License revenue
10
Research and development
19.639
General and administrative
3.689
Total operating expenses
23.328
Loss from operations
-13.328
Interest income
0.862
Other expense, net
0.009
Total other income, net
0.853
Net loss
-12.475
Earnings per share, basic
-8.07
Earnings per share, diluted
-8.07
Weighted average number of shares outstanding, basic
1,545,010
Weighted average number of shares outstanding, diluted
1,545,010
Unit: Million (M) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income$0.862M Net loss-$12.475M Total other income,net$0.853M Other expense, net$0.009M Loss from operations-$13.328M License revenue$10M Total operatingexpenses$23.328M General andadministrative$3.689M Research and development$19.639M

Evommune, Inc. (EVMN)

Evommune, Inc. (EVMN)